| PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
12.840 |
Evidence |
|
| DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
12.840 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
12.840 |
Evidence |
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
EXOC2 |
IPI00215805 |
12.840 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
12.820 |
Evidence |
|
| LIMK1 |
LIMK1, LIMK: LIM domain kinase 1 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
12.820 |
Evidence |
|
| FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
12.800 |
Evidence |
|
| CST9L |
CST9L, UNQ1835/PRO3543: Cystatin-9-like precursor |
HSDL1 |
CDNA FLJ90397 fis, clone NT2RP2005878, moderately similar to PUTATIVE STEROID DE |
12.800 |
Evidence |
|
| KCNH8 |
KCNH8: Potassium voltage-gated channel subfamily H member 8 |
TRPM6 |
TRPM6, CHAK2: Transient receptor potential cation channel subfamily M member 6 |
12.800 |
Evidence |
|
| TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
12.800 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
12.800 |
Evidence |
|
| BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
12.800 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
SERPINA9 |
IPI00651735 |
12.800 |
Evidence |
|
| TRPM2 |
TRPM2, EREG1, KNP3, LTRPC2, TRPC7: Transient receptor potential cation channel s |
KCNH4 |
KCNH4: Potassium voltage-gated channel subfamily H member 4 |
12.800 |
Evidence |
|
| TRPM2 |
TRPM2, EREG1, KNP3, LTRPC2, TRPC7: Transient receptor potential cation channel s |
KCNG1 |
KCNG1: Potassium voltage-gated channel subfamily G member 1 |
12.800 |
Evidence |
|
| TRPM2 |
TRPM2, EREG1, KNP3, LTRPC2, TRPC7: Transient receptor potential cation channel s |
KCNH8 |
KCNH8: Potassium voltage-gated channel subfamily H member 8 |
12.800 |
Evidence |
|
| TRPM2 |
TRPM2, EREG1, KNP3, LTRPC2, TRPC7: Transient receptor potential cation channel s |
CACNA1H |
CACNA1H: Voltage-dependent T-type calcium channel subunit alpha-1H |
12.800 |
Evidence |
|
| HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
TRPM6 |
TRPM6, CHAK2: Transient receptor potential cation channel subfamily M member 6 |
12.800 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
12.800 |
Evidence |
|
| TNFRSF10B |
TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9: Tumor necrosis factor receptor |
DDX58 |
DDX58: Probable ATP-dependent RNA helicase DDX58 |
12.800 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
12.800 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BID |
BID: BH3-interacting domain death agonist |
12.800 |
Evidence |
|
| CNGB3 |
CNGB3: Cyclic nucleotide-gated cation channel beta 3 |
KCNA3 |
KCNA3, RP11-284N8.2-001, hCG_1642166: Potassium voltage-gated channel, shaker-re |
12.790 |
Evidence |
|
| NEUROD4 |
NEUROD4, ATOH3: Neurogenic differentiation factor 4 |
MLXIP |
MLXIP, KIAA0867, MIR: MLX-interacting protein |
12.790 |
Evidence |
|
| SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
JAK1 |
|
12.790 |
Evidence |
|
- 
-